Neogen
NEOG
$12.14
Share price
1.51%
Change (1 day)
-29.13%
Change (1 year)
Neogen (NEOG) - Total liabilities
Total liabilities on the balance sheet as of November 2023 : $1.45 B
According to Neogen's latest financial reports the company's total liabilities are $1.45 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Neogen - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-05-31 | $1.42 B | 1245.47% |
| 2022-05-31 | $0.10 B | 32.25% |
| 2021-05-31 | $79.81 M | 10.85% |
| 2020-05-31 | $72 M | 24.49% |
| 2019-05-31 | $57.84 M | 0.01% |
| 2018-05-31 | $57.83 M | 2.09% |
| 2017-05-31 | $56.65 M | 23.75% |
| 2016-05-31 | $45.77 M | 11.07% |
| 2015-05-31 | $41.21 M | 5.68% |
| 2014-05-31 | $39 M | 20.85% |
| 2013-05-31 | $32.27 M | -0.84% |
| 2012-05-31 | $32.54 M | 6.07% |
| 2011-05-31 | $30.68 M | 12.89% |
| 2010-05-31 | $27.18 M | 101.38% |
| 2009-05-31 | $13.49 M | -10.67% |
| 2008-05-31 | $15.1 M | 13.27% |
| 2007-05-31 | $13.33 M | -41.66% |
| 2006-05-31 | $22.86 M | 152.69% |
| 2005-05-31 | $9.04 M | -25.42% |
| 2004-05-31 | $12.13 M | 82.89% |
| 2003-05-31 | $6.63 M | 52.23% |
| 2002-05-31 | $4.35 M | 18.26% |
| 2001-05-31 | $3.68 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.88 B | 3,466.28% | 🇺🇸 USA |
 Becton Dickinson BDX | $26.94 B | 1,751.81% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | $1.77 B | 22.03% | 🇺🇸 USA |
 Illumina ILMN | $4.36 B | 200.10% | 🇺🇸 USA |
 Danaher DHR | $29.95 B | 1,958.98% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 353.95% | 🇺🇸 USA |
 Pacific Biosciences
PACB | $1.04 B | -28.19% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $95.03 M | -93.47% | 🇺🇸 USA |